Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease

The AGILITY study reached full enrollment for the iliac artery cohort, evaluating the Revello Vascular Covered Stent designed to improve treatment for over 21 million Americans with PAD.

Summary by WFMZ
FRANKLIN LAKES, N.J., Nov. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device Exemption (IDE) study, a…

2 Articles

medicaleconomics.commedicaleconomics.com
Center

BD completes iliac cohort enrollment in AGILITY study evaluating Revello stent for peripheral artery disease

Medical Economics serves as the connection to Physician Practice Management, featuring financial strategies, business insights, and expert interviews.

Read Full Article
WFMZWFMZ
Center

BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease

FRANKLIN LAKES, N.J., Nov. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device Exemption (IDE) study, a…

·Pennsylvania, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WFMZ broke the news in Pennsylvania, United States on Tuesday, November 4, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Franklin Lakes icon

Franklin Lakes

News
For You
SearchBlindspotLocal